Click for best price
Precancer Molecular Diagnostics Market Size, Share 2023
A molecular approach for diagnosing precancer
This report aims to provide a comprehensive presentation of the global market for Precancer Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Precancer Molecular Diagnostics. This report contains market size and forecasts of Precancer Molecular Diagnostics in global, including the following market information:
Global Precancer Molecular Diagnostics Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Precancer Molecular Diagnostics market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
PCR Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Precancer Molecular Diagnostics include Genetronhealth, Sanvalley, Premed, Gene+, Annoroad, Topgen, Anpac, Kingmed and Unitedgene, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Precancer Molecular Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Precancer Molecular Diagnostics Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Precancer Molecular Diagnostics Market Segment Percentages, by Type, 2022 (%)
PCR
FISH
DNA Sequencing
Gene Chip
Global Precancer Molecular Diagnostics Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Precancer Molecular Diagnostics Market Segment Percentages, by Application, 2022 (%)
Clinical Diagnosis
Drug Screening
Research
Global Precancer Molecular Diagnostics Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Precancer Molecular Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Precancer Molecular Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Precancer Molecular Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Genetronhealth
Sanvalley
Premed
Gene+
Annoroad
Topgen
Anpac
Kingmed
Unitedgene
Roche
Foundationmedicine
Outline of Major Chapters:
Chapter 1: Introduces the definition of Precancer Molecular Diagnostics, market overview.
Chapter 2: Global Precancer Molecular Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Precancer Molecular Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Precancer Molecular Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Precancer Molecular Diagnostics Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
63 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Precancer Molecular Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Precancer Molecular Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Precancer Molecular Diagnostics Overall Market Size
2.1 Global Precancer Molecular Diagnostics Market Size: 2022 VS 2030
2.2 Global Precancer Molecular Diagnostics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Precancer Molecular Diagnostics Players in Global Market
3.2 Top Global Precancer Molecular Diagnostics Companies Ranked by Revenue
3.3 Global Precancer Molecular Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Precancer Molecular Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Precancer Molecular Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Precancer Molecular Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Precancer Molecular Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Precancer Molecular Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Precancer Molecular Diagnostics Market Size Markets, 2022 & 2030
4.1.2 PCR
4.1.3 FISH
4.1.4 DNA Sequencing
4.1.5 Gene Chip
4.2 By Type - Global Precancer Molecular Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Precancer Molecular Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global Precancer Molecular Diagnostics Revenue, 2024-2030
4.2.3 By Type - Global Precancer Molecular Diagnostics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Precancer Molecular Diagnostics Market Size, 2022 & 2030
5.1.2 Clinical Diagnosis
5.1.3 Drug Screening
5.1.4 Research
5.2 By Application - Global Precancer Molecular Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Precancer Molecular Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global Precancer Molecular Diagnostics Revenue, 2024-2030
5.2.3 By Application - Global Precancer Molecular Diagnostics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Precancer Molecular Diagnostics Market Size, 2022 & 2030
6.2 By Region - Global Precancer Molecular Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Precancer Molecular Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global Precancer Molecular Diagnostics Revenue, 2024-2030
6.2.3 By Region - Global Precancer Molecular Diagnostics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Precancer Molecular Diagnostics Revenue, 2018-2030
6.3.2 US Precancer Molecular Diagnostics Market Size, 2018-2030
6.3.3 Canada Precancer Molecular Diagnostics Market Size, 2018-2030
6.3.4 Mexico Precancer Molecular Diagnostics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Precancer Molecular Diagnostics Revenue, 2018-2030
6.4.2 Germany Precancer Molecular Diagnostics Market Size, 2018-2030
6.4.3 France Precancer Molecular Diagnostics Market Size, 2018-2030
6.4.4 U.K. Precancer Molecular Diagnostics Market Size, 2018-2030
6.4.5 Italy Precancer Molecular Diagnostics Market Size, 2018-2030
6.4.6 Russia Precancer Molecular Diagnostics Market Size, 2018-2030
6.4.7 Nordic Countries Precancer Molecular Diagnostics Market Size, 2018-2030
6.4.8 Benelux Precancer Molecular Diagnostics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Precancer Molecular Diagnostics Revenue, 2018-2030
6.5.2 China Precancer Molecular Diagnostics Market Size, 2018-2030
6.5.3 Japan Precancer Molecular Diagnostics Market Size, 2018-2030
6.5.4 South Korea Precancer Molecular Diagnostics Market Size, 2018-2030
6.5.5 Southeast Asia Precancer Molecular Diagnostics Market Size, 2018-2030
6.5.6 India Precancer Molecular Diagnostics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Precancer Molecular Diagnostics Revenue, 2018-2030
6.6.2 Brazil Precancer Molecular Diagnostics Market Size, 2018-2030
6.6.3 Argentina Precancer Molecular Diagnostics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Precancer Molecular Diagnostics Revenue, 2018-2030
6.7.2 Turkey Precancer Molecular Diagnostics Market Size, 2018-2030
6.7.3 Israel Precancer Molecular Diagnostics Market Size, 2018-2030
6.7.4 Saudi Arabia Precancer Molecular Diagnostics Market Size, 2018-2030
6.7.5 UAE Precancer Molecular Diagnostics Market Size, 2018-2030
7 Precancer Molecular Diagnostics Companies Profiles
7.1 Genetronhealth
7.1.1 Genetronhealth Company Summary
7.1.2 Genetronhealth Business Overview
7.1.3 Genetronhealth Precancer Molecular Diagnostics Major Product Offerings
7.1.4 Genetronhealth Precancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.1.5 Genetronhealth Key News & Latest Developments
7.2 Sanvalley
7.2.1 Sanvalley Company Summary
7.2.2 Sanvalley Business Overview
7.2.3 Sanvalley Precancer Molecular Diagnostics Major Product Offerings
7.2.4 Sanvalley Precancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.2.5 Sanvalley Key News & Latest Developments
7.3 Premed
7.3.1 Premed Company Summary
7.3.2 Premed Business Overview
7.3.3 Premed Precancer Molecular Diagnostics Major Product Offerings
7.3.4 Premed Precancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.3.5 Premed Key News & Latest Developments
7.4 Gene+
7.4.1 Gene+ Company Summary
7.4.2 Gene+ Business Overview
7.4.3 Gene+ Precancer Molecular Diagnostics Major Product Offerings
7.4.4 Gene+ Precancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.4.5 Gene+ Key News & Latest Developments
7.5 Annoroad
7.5.1 Annoroad Company Summary
7.5.2 Annoroad Business Overview
7.5.3 Annoroad Precancer Molecular Diagnostics Major Product Offerings
7.5.4 Annoroad Precancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.5.5 Annoroad Key News & Latest Developments
7.6 Topgen
7.6.1 Topgen Company Summary
7.6.2 Topgen Business Overview
7.6.3 Topgen Precancer Molecular Diagnostics Major Product Offerings
7.6.4 Topgen Precancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.6.5 Topgen Key News & Latest Developments
7.7 Anpac
7.7.1 Anpac Company Summary
7.7.2 Anpac Business Overview
7.7.3 Anpac Precancer Molecular Diagnostics Major Product Offerings
7.7.4 Anpac Precancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.7.5 Anpac Key News & Latest Developments
7.8 Kingmed
7.8.1 Kingmed Company Summary
7.8.2 Kingmed Business Overview
7.8.3 Kingmed Precancer Molecular Diagnostics Major Product Offerings
7.8.4 Kingmed Precancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.8.5 Kingmed Key News & Latest Developments
7.9 Unitedgene
7.9.1 Unitedgene Company Summary
7.9.2 Unitedgene Business Overview
7.9.3 Unitedgene Precancer Molecular Diagnostics Major Product Offerings
7.9.4 Unitedgene Precancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.9.5 Unitedgene Key News & Latest Developments
7.10 Roche
7.10.1 Roche Company Summary
7.10.2 Roche Business Overview
7.10.3 Roche Precancer Molecular Diagnostics Major Product Offerings
7.10.4 Roche Precancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.10.5 Roche Key News & Latest Developments
7.11 Foundationmedicine
7.11.1 Foundationmedicine Company Summary
7.11.2 Foundationmedicine Business Overview
7.11.3 Foundationmedicine Precancer Molecular Diagnostics Major Product Offerings
7.11.4 Foundationmedicine Precancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.11.5 Foundationmedicine Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Precancer Molecular Diagnostics Market Opportunities & Trends in Global Market
Table 2. Precancer Molecular Diagnostics Market Drivers in Global Market
Table 3. Precancer Molecular Diagnostics Market Restraints in Global Market
Table 4. Key Players of Precancer Molecular Diagnostics in Global Market
Table 5. Top Precancer Molecular Diagnostics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Precancer Molecular Diagnostics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Precancer Molecular Diagnostics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Precancer Molecular Diagnostics Product Type
Table 9. List of Global Tier 1 Precancer Molecular Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Precancer Molecular Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Precancer Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Precancer Molecular Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Precancer Molecular Diagnostics Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Precancer Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Precancer Molecular Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Precancer Molecular Diagnostics Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Precancer Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Precancer Molecular Diagnostics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Precancer Molecular Diagnostics Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Precancer Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Precancer Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Precancer Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Precancer Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Precancer Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 30. Genetronhealth Company Summary
Table 31. Genetronhealth Precancer Molecular Diagnostics Product Offerings
Table 32. Genetronhealth Precancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 33. Genetronhealth Key News & Latest Developments
Table 34. Sanvalley Company Summary
Table 35. Sanvalley Precancer Molecular Diagnostics Product Offerings
Table 36. Sanvalley Precancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 37. Sanvalley Key News & Latest Developments
Table 38. Premed Company Summary
Table 39. Premed Precancer Molecular Diagnostics Product Offerings
Table 40. Premed Precancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 41. Premed Key News & Latest Developments
Table 42. Gene+ Company Summary
Table 43. Gene+ Precancer Molecular Diagnostics Product Offerings
Table 44. Gene+ Precancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 45. Gene+ Key News & Latest Developments
Table 46. Annoroad Company Summary
Table 47. Annoroad Precancer Molecular Diagnostics Product Offerings
Table 48. Annoroad Precancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 49. Annoroad Key News & Latest Developments
Table 50. Topgen Company Summary
Table 51. Topgen Precancer Molecular Diagnostics Product Offerings
Table 52. Topgen Precancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 53. Topgen Key News & Latest Developments
Table 54. Anpac Company Summary
Table 55. Anpac Precancer Molecular Diagnostics Product Offerings
Table 56. Anpac Precancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 57. Anpac Key News & Latest Developments
Table 58. Kingmed Company Summary
Table 59. Kingmed Precancer Molecular Diagnostics Product Offerings
Table 60. Kingmed Precancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 61. Kingmed Key News & Latest Developments
Table 62. Unitedgene Company Summary
Table 63. Unitedgene Precancer Molecular Diagnostics Product Offerings
Table 64. Unitedgene Precancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 65. Unitedgene Key News & Latest Developments
Table 66. Roche Company Summary
Table 67. Roche Precancer Molecular Diagnostics Product Offerings
Table 68. Roche Precancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 69. Roche Key News & Latest Developments
Table 70. Foundationmedicine Company Summary
Table 71. Foundationmedicine Precancer Molecular Diagnostics Product Offerings
Table 72. Foundationmedicine Precancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 73. Foundationmedicine Key News & Latest Developments
List of Figures
Figure 1. Precancer Molecular Diagnostics Segment by Type in 2022
Figure 2. Precancer Molecular Diagnostics Segment by Application in 2022
Figure 3. Global Precancer Molecular Diagnostics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Precancer Molecular Diagnostics Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Precancer Molecular Diagnostics Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Precancer Molecular Diagnostics Revenue in 2022
Figure 8. By Type - Global Precancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 9. By Application - Global Precancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 10. By Type - Global Precancer Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Precancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 12. By Application - Global Precancer Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Precancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 14. By Region - Global Precancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 15. By Country - North America Precancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 16. US Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Precancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 20. Germany Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 21. France Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Precancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 28. China Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 32. India Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Precancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 34. Brazil Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Precancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 37. Turkey Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Precancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 41. Genetronhealth Precancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Sanvalley Precancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Premed Precancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Gene+ Precancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Annoroad Precancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Topgen Precancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Anpac Precancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Kingmed Precancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Unitedgene Precancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Roche Precancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Foundationmedicine Precancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
